43
Views
19
CrossRef citations to date
0
Altmetric
Original Article

Elevated IL-10 Inhibits GM-CSF Synthesis in Pulmonary Alveolar Proteinosis

, , , , , & show all
Pages 285-290 | Received 28 Apr 2003, Accepted 22 May 2003, Published online: 07 Jul 2009

References

  • Walters, L.C. (1988) "Chronic alveolar filling disease", In: Schwarz, M. and King, T.E., eds, Interstitial Lung Disease (B.C. Decker, Philadelphia), pp 239–281.
  • Mazzone, P., Thomassen, M.J. and Kavuru, M. (2001) "Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know", Clev. Clin. J. Med. 68, 977–992.
  • Reed, J.A., Ikegami, M., Cianciolo, ER., et al. (1999) "Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF-deficient mice", Am. J. PhysioL 276, L556—L563.
  • Dranoff, G., Crawford, AD., Sadelain, M., et al. (1994) "Involvement of granulocyte-macrophage colony-stimulating fac-tor in pulmonary homeostasis", Science 264, 713–716.
  • Stanley, E., Lieschke, G.J., Grail, D., et al. (1994) "Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology", Proc. Nati Acad. Sci. USA 91, 5592–5596.
  • Huffman, J.A., Hull, W.M., Dranoff, G., Mulligan, R.C. and Whitsett, J.A. (1995) "Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice", J. Clin. Investig. 97, 649–655.
  • Kitamura, T., Tanaka, N., Watanabe, J., et al. (1999) "Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor", J. Exp. Med. 190, 875–880.
  • Tanaka, N., Watanabe, J., Kitamura, T., Yamada, Y, Kanegasald, S. and Nakata, K. (1999) "Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony-stimulating factor", FEBS Lett. 442, 246–250.
  • Thomassen, M.J., Yi, T., Raychaudhuri, B., Malur, A. and Kavuru, M.S. (2000) "Pulmonary alveolar proteinosis is a disease of decreased availability of GM-CSF rather than an intrinsic cellular defect", Clin. ImmunoL 95, 85–92.
  • Bonfield, T.L., Russell, D., Burgess, S., Malur, A., Kavuru, MS. and Thomassen, M.J. (2002) "Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis", Am. J. Respir. Cell MoL Biol. 27, 481–486.
  • Bonfield, T.L., Kavuru, MS. and Thomassen, M.J. (2002) "Anti-GM-CSF titer predicts response to GM-CSF therapy in pulmonary alveolar proteinosis", Clin. ImmunoL 105, 342–350.
  • Moore, K.W., de Waal Malefyt, R., Coffman, R.L. and O'Garra, A. (2001) "Interleukin-10 and the interleukin-10 receptor", Annu. Rev. ImmunoL 19, 683–765.
  • Donnelly, R.P., Dickensheets, H.L. and Finbloom, D.S. (1999) "The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes", J. Interferon Cytokine Res. 19, 563–573.
  • Thomassen, M.J., Divis, L.T. and Fisher, C.J. (1996) "Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10", Clin. ImmunoL Immunopathol. 80, 321–324.
  • Llorente, L., Zou, W., Levy, Y, et al. (1995) "Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus", J. Exp. Med. 181, 839–844.
  • Tchou-Wong, K.-M., Harkin, T.J., Chi, C., Bodkin, M. and Rom, W.N. (1997) "GM-CSF gene expression is normal but protein release is absent in a patient with pulmonary alveolar proteinosis", Am. J. Respir. Grit. Care Med. 156, 1999–2002.
  • Kavuru, M.S., Sullivan, E.J., Piccin, R., Thomassen, M.J. and Stoller, J.K. (2000) "Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis", Am. J. Bevil-. Grit. Care Med. 161, 1143–1148.
  • Thomassen, M.J., Buhrow, L.T., Connors, M.J., Kaneko, RT., Erzurum, S.C. and Kavuni, US. (1997) "Nitric oxide inhibits inflammatory cytokine production by human alveolar macro-phages", Am. J. Bevil-. Cell MoL Biol. 17, 279–283.
  • Thomassen, M.J., Antal, J.M., Connors, M.J., Meeker, DR and Wiedemann, H.P. (1994) "Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses", Am. J. Bevil-. Cell Mol. Biol. 10, 399–404.
  • Raychaudhuri, B., Fisher, C.J., Farver, C.F., et al. (2000) "Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages", Cytokine 12, 1348–1355.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.